Ten years ago, a Columbia postdoc identified a simple nutrient that can alleviate Parkinson’s disease symptoms in mice by rewiring the brain. It’s finally being put to the test in people.
The new report addresses the responsible use of race and ethnicity in biomedical research and is a call to action for biomedical research to rethink how it uses race and ethnicity.
Timely discussions about the goals of care ensure that nursing home residents receive care that aligns with their wishes but are less likely in homes with a higher percentage of Black residents.
Based on an analysis of withdrawn drugs that gained approval through the FDA's fast-track program, Columbia researchers argue that such programs have positively contributed to drug development.
A team of Columbia scientists is examining patient samples and experimenting with organoids to understand why colon cancer is on the rise in people under 50.
Columbia MD/PhD student Deirdre Ricaurte is using new genomics methods to understand how prescription drugs disturb our gut microbiome and the health consequences of these “drug-bug” interactions.
Hachung Chung’s curiosity about the immune system is now leading her to delve into a longstanding question: Why is the brain so prone to inflammation in the absence of pathogens?
A study by Columbia researchers found that prenatal exposure to general anesthesia is associated with a 31% increased risk of being diagnosed with a behavioral disorder during childhood.
Just before turning 40, Larry Abbott switched from physics to theoretical neuroscience. Now, a few decades later, his contributions to brain science have been recognized with the 2024 Brain Prize.
Columbia neuroscientists have uncovered evidence for a new form of collective sensing that appears to enable elephantnose fish to extend their perceptual reach.